Therefore, we have reason to speculate that by inhibiting the PI3K/AKT pathway, AdP further inhibits YB1 phosphorylation and reduces MDR1 expression to increase the sensitivity of GC cells to CDDP. The gene discussed is AKT1; the disease is gastric cancer.